Deoxylytics White Paper

Many thanks to Zoey Chopra and Adam Holmes for their contributions to our company white paper. Zoey is completing a dual M.D./Ph.D. at the University of Michigan; he is pursuing a Ph.D. in Economics. Adam is a medical student at the University of Michigan with an interest in pursuing a procedurally oriented specialty.

In our white paper, we have broadly outlined the pharmacogenomics landscape as it currently stands as a means of informing future clients, investors, and the general public of where Deoxylytics has positioned itself within the larger pharmacogenomics ecosystem. The white paper (Applying Phenotypic Diagnoses and Genomic Variants to Clinical Practice) is included below.